Ryan Kubota
Director of Investor Relations
Replay available
InnovAge Holding Corp. (NASDAQ: INNV) Q1 2026 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Director of Investor Relations
Chief Growth Officer
Chief Executive Officer
Chief Financial Officer
Analyst, J.P. Morgan
Analyst, KeyBank
Good day and thank you for standing by. Welcome to the InnovAge first quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Ryan Kubota, Director of Investor Relations. Please go ahead. Thank you, operator. Good afternoon, and thank you all for joining the InnoVage 2026 Fiscal First Quarter Earnings Call. With me today is Patrick Blair, CEO, and Ben Adams, CFO. Today, after the market closed, we issued an earnings press release containing detailed information on our fiscal first quarter results. you may access the release on the investor relations section of our company website, innovates.com. For those listening to the rebroadcast of this call, we remind you that the remarks made herein are as of today, Tuesday, November 4th, 2025, and have not been updated subsequent to this call. During our call, we refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in our earnings pressure release posted on our website. We may also make statements that are considered forward-looking, including those related to our 2026 fiscal year projections and guidance, future growth prospects and growth strategy, our clinical and operational value initiatives, Medicare and Medicaid rate increases, the effects of recent legislation and federal budget cu...